Detalhe da pesquisa
1.
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.
Breast Cancer Res Treat
; 171(1): 121-129, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752687
2.
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer.
Breast Cancer Res Treat
; 131(3): 915-24, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22076478
3.
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board.
JCO Precis Oncol
; 20172017.
Artigo
em Inglês
| MEDLINE | ID: mdl-30003184
4.
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study.
Clin Cancer Res
; 23(11): 2691-2701, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27979916
5.
Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer.
Clin Cancer Res
; 23(2): 379-386, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27489289
6.
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer.
Clin Cancer Res
; 19(14): 4008-16, 2013 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23719261
7.
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood.
Clin Cancer Res
; 18(12): 3462-9, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22421194
8.
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.
J Clin Oncol
; 27(22): e35-7; author reply e38-9, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19564528